Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 May 16;385(9981):1993-2002.
doi: 10.1016/S0140-6736(15)60907-2.

Autosomal dominant polycystic kidney disease: the changing face of clinical management

Collaborators, Affiliations
Review

Autosomal dominant polycystic kidney disease: the changing face of clinical management

Albert C M Ong et al. Lancet. .

Erratum in

  • Department of Error.
    [No authors listed] [No authors listed] Lancet. 2015 Jun 27;385(9987):2576. doi: 10.1016/S0140-6736(15)61160-6. Lancet. 2015. PMID: 26122160 No abstract available.

Abstract

Autosomal dominant polycystic kidney disease is the most common inherited kidney disease and accounts for 7-10% of all patients on renal replacement therapy worldwide. Although first reported 500 years ago, this disorder is still regarded as untreatable and its pathogenesis is poorly understood despite much study. During the past 40 years, however, remarkable advances have transformed our understanding of how the disease develops and have led to rapid changes in diagnosis, prognosis, and treatment, especially during the past decade. This Review will summarise the key findings, highlight recent developments, and look ahead to the changes in clinical practice that will likely arise from the adoption of a new management framework for this major kidney disease.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources